Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vertex Pharmaceuticals Inc. buy Guggenheim

Vertex Pharmaceuticals Inc.
Start price
€329.95
06.08.25 / 50%
Target price
€471.96
06.08.26
Performance (%)
27.73%
End price
€421.45
07.08.26
Summary
This prediction ended on 07.08.26 with a price of €421.45. The BUY prediction by Guggenheim finished with a performance of 27.73%. Guggenheim has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Vertex Pharmaceuticals Inc. 1.794% 1.794% 30.360%
iShares Core DAX® 0,44 % 5,64 % 7,81 %
iShares Nasdaq 100 1,06 % 0,28 % 27,24 %
iShares Nikkei 225® 1,77 % 0,41 % 49,27 %
iShares S&P 500 0,37 % 1,92 % 22,34 %

Comments by Guggenheim for this prediction

In the thread Trading Vertex Pharmaceuticals Inc.
Prediction Buy
Perf. (%) 27.73%
Target price 471.962
Change
Ends at 06.08.26

Die von Guggenheim gewählte maximale Laufzeit wurde überschritten

Guggenheim 
0
Report Share
07.08.26
In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 27.73%
Target price 471.962
Change
Ends at 06.08.26

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Guggenheim from $558.00 to $546.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat

Guggenheim 
0
Report Share
06.08.25

Stopped prediction by Guggenheim for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€453.20
02.08.24
€511.18
02.08.25
-11.90%
03.08.25

Guggenheim 
02.08.24 50%